Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Scarpi

Showing results (41-50 of 215) with videos related to

Pageof 22
Sort By:
American Journal of Clinical Oncology|September 20, 2011
Noninferiority trials in second-line treatments of nonsmall cell lung cancer: a systematic review of literature with meta-analysis of phase III randomized clinical trialsDavide Tassinari, Emanuela Scarpi, Sergio Sartori, et al.
JCO Precision Oncology|January 31, 2024
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized TrialElisabetta Petracci, Alessandro Passardi, Annibale Biggeri, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
Oncology|December 22, 2012
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impactToni Ibrahim, Alberto Farolfi, Emanuela Scarpi, et al.
The Oncologist|October 25, 2014
Clinical and genetic factors related to cancer-induced bone pain and bone pain reliefEmanuela Scarpi, Daniele Calistri, Pål Klepstad, et al.
International Journal of Cancer|February 22, 2002
Vascular endothelial growth factor and prognosis in patients with node-negative breast cancerFranca De Paola, Anna Maria Granato, Emanuela Scarpi, et al.
Oncology Letters|February 10, 2015
<i>EGFR</i> methylation and outcome of patients with advanced colorectal cancer treated with cetuximabElisa Chiadini, Emanuela Scarpi, Alessandro Passardi, et al.
International Journal of Molecular Sciences|May 21, 2020
Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer PatientsFrancesca Pirini, Luigi Pasini, Gianluca Tedaldi, et al.
Journal of Translational Medicine|September 24, 2014
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic responseLaura Ridolfi, Francesco de Rosa, Ruggero Ridolfi, et al.
International Journal of Molecular Sciences|January 25, 2018
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal CancerPaola Ulivi, Matteo Canale, Alessandro Passardi, et al.
Pageof 22

Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
American Journal of Clinical Oncology|September 20, 2011
Noninferiority trials in second-line treatments of nonsmall cell lung cancer: a systematic review of literature with meta-analysis of phase III randomized clinical trialsDavide Tassinari, Emanuela Scarpi, Sergio Sartori, et al.
JCO Precision Oncology|January 31, 2024
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized TrialElisabetta Petracci, Alessandro Passardi, Annibale Biggeri, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
Oncology|December 22, 2012
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impactToni Ibrahim, Alberto Farolfi, Emanuela Scarpi, et al.
The Oncologist|October 25, 2014
Clinical and genetic factors related to cancer-induced bone pain and bone pain reliefEmanuela Scarpi, Daniele Calistri, Pål Klepstad, et al.
International Journal of Cancer|February 22, 2002
Vascular endothelial growth factor and prognosis in patients with node-negative breast cancerFranca De Paola, Anna Maria Granato, Emanuela Scarpi, et al.
Oncology Letters|February 10, 2015
<i>EGFR</i> methylation and outcome of patients with advanced colorectal cancer treated with cetuximabElisa Chiadini, Emanuela Scarpi, Alessandro Passardi, et al.
International Journal of Molecular Sciences|May 21, 2020
Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer PatientsFrancesca Pirini, Luigi Pasini, Gianluca Tedaldi, et al.
Journal of Translational Medicine|September 24, 2014
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic responseLaura Ridolfi, Francesco de Rosa, Ruggero Ridolfi, et al.
International Journal of Molecular Sciences|January 25, 2018
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal CancerPaola Ulivi, Matteo Canale, Alessandro Passardi, et al.
Pageof 22